Human Study Shows Protandim(R) Provides a Fundamentally New Approach to Antioxidant Therapy

Human Study Shows Protandim(R) Provides a Fundamentally New Approach to Antioxidant Therapy Company announces data from a human study just published in the journal, Free Radical Biology & Medicine, which indicate that Protandim(R) was able to reduce oxidative stress in men and women, by inducing the body to produce more of its own antioxidant enzymes.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Biogaia Releases Results From Allergy Study Study done in collaboration with the Centre for Allergy Research at the Karolinska Institutet and including 232 newborn infants at four paediatric allergy clinics in Sweden, showed that babies that were supplemented with Reuteri showed significantly higher levels of the live bacteria in their gastrointestinal tracts, but the incidence of eczema , the main clinical manifestations of allergy in the first 2 years of life was, however, not significantly affected by supplementation with Reuteri. Biogaia Releases Results From Allergy Study Study done in collaboration with the Centre for Allergy Research at the Karolinska Institutet and including 232 newborn infants at four paediatric allergy clinics in Sweden, showed that babies that were supplemented with Reuteri showed significantly higher levels of the live bacteria in their gastrointestinal tracts, but the incidence of eczema , the main clinical manifestations of allergy in the first 2 years of life was, however, not significantly affected by supplementation with Reuteri. Biogaia Releases Results From Allergy Study Study done in collaboration with the Centre for Allergy Research at the Karolinska Institutet and including 232 newborn infants at four paediatric allergy clinics in Sweden, showed that babies that were supplemented with Reuteri showed significantly higher levels of the live bacteria in their gastrointestinal tracts, but the incidence of eczema , the main clinical manifestations of allergy in the first 2 years of life was, however, not significantly affected by supplementation with Reuteri. Biogaia Releases Results From Allergy Study Study done in collaboration with the Centre for Allergy Research at the Karolinska Institutet and including 232 newborn infants at four paediatric allergy clinics in Sweden, showed that babies that were supplemented with Reuteri showed significantly higher levels of the live bacteria in their gastrointestinal tracts, but the incidence of eczema , the main clinical manifestations of allergy in the first 2 years of life was, however, not significantly affected by supplementation with Reuteri. L-Arginine Therapy Examined in Acute Myocardial Infarction Research published in JAMA describes a study involving subjects who had had heart attacks and continued to have symptoms of heart disease, supplemented with L-arginine. L-Arginine Therapy Examined in Acute Myocardial Infarction Research published in JAMA describes a study involving subjects who had had heart attacks and continued to have symptoms of heart disease, supplemented with L-arginine. Should The Public Be Wary of Arginine Supplements Bill Sardi comments on the January 4 issue of the Journal of the American Medical Association which reported that L-arginine supplementation resulted in the deaths of six patients versus none in an un-supplemented group. Should The Public Be Wary of Arginine Supplements Bill Sardi comments on the January 4 issue of the Journal of the American Medical Association which reported that L-arginine supplementation resulted in the deaths of six patients versus none in an un-supplemented group. Vitamin D Supplementation During Pregnancy Could Reduce Osteoporosis In Children Study published in this week’s issue of The Lancet indicates that children whose mothers were lacking in vitamin D during pregnancy grow up to have weaker bones. Vitamin D Supplementation During Pregnancy Could Reduce Osteoporosis In Children Study published in this week’s issue of The Lancet indicates that children whose mothers were lacking in vitamin D during pregnancy grow up to have weaker bones. Vitamin D Supplementation During Pregnancy Could Reduce Osteoporosis In Children Study published in this week’s issue of The Lancet indicates that children whose mothers were lacking in vitamin D during pregnancy grow up to have weaker bones. Vitamin D Supplementation During Pregnancy Could Reduce Osteoporosis In Children Study published in this week’s issue of The Lancet indicates that children whose mothers were lacking in vitamin D during pregnancy grow up to have weaker bones. Research Examines Effect of Enzymotec Product on Children's Cognitive Performance Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance. Research Examines Effect of Enzymotec Product on Children's Cognitive Performance Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance. Research Examines Effect of Enzymotec Product on Children's Cognitive Performance Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance. Research Examines Effect of Enzymotec Product on Children's Cognitive Performance Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance. Research Examines Effect of Enzymotec Product on Children's Cognitive Performance Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance. ForsLean Favorably Alters Body Composition According to Study Published in the Journal of the International Society of Sports Nutrition A study published in the December 2005 Journal of the International Society of Sports Nutrition (www.theissn.org) entitled "Effects of Coleus forskohlii extract supplementation on body composition and markers of health in sedentary overweight females" confirmed that ForsLean(R), Sabinsa Corporation's patented Coleus forskohlii extract promotes favorable changes in body composition. ForsLean Favorably Alters Body Composition According to Study Published in the Journal of the International Society of Sports Nutrition A study published in the December 2005 Journal of the International Society of Sports Nutrition (www.theissn.org) entitled "Effects of Coleus forskohlii extract supplementation on body composition and markers of health in sedentary overweight females" confirmed that ForsLean(R), Sabinsa Corporation's patented Coleus forskohlii extract promotes favorable changes in body composition. Quebec, Ontario Researchers to do Study on Treating Depression with Omega-3 In a study that will finish in the fall of 2007 and will receive funding from the European company Isodisnatura, Canadian researchers are examining the effect of omega-3 from fish oil and its ability to treat major depression. Quebec, Ontario Researchers to do Study on Treating Depression with Omega-3 In a study that will finish in the fall of 2007 and will receive funding from the European company Isodisnatura, Canadian researchers are examining the effect of omega-3 from fish oil and its ability to treat major depression. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. ImmunoLin® Improves Quality of Life in New IBS Study Company conducted double-blind placebo controlled six week study on 51 patients, observing that overall days with symptoms decreased by 16% and 18% in the 5 gm ImmunoLin and 10 gm ImmunoLin groups, respectively, compared to the soy protein control group. ImmunoLin® Improves Quality of Life in New IBS Study Company conducted double-blind placebo controlled six week study on 51 patients, observing that overall days with symptoms decreased by 16% and 18% in the 5 gm ImmunoLin and 10 gm ImmunoLin groups, respectively, compared to the soy protein control group. ImmunoLin® Improves Quality of Life in New IBS Study Company conducted double-blind placebo controlled six week study on 51 patients, observing that overall days with symptoms decreased by 16% and 18% in the 5 gm ImmunoLin and 10 gm ImmunoLin groups, respectively, compared to the soy protein control group. ImmunoLin® Improves Quality of Life in New IBS Study Company conducted double-blind placebo controlled six week study on 51 patients, observing that overall days with symptoms decreased by 16% and 18% in the 5 gm ImmunoLin and 10 gm ImmunoLin groups, respectively, compared to the soy protein control group. New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax. New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax. New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax. New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax. New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax. Study Compares Regulation of Conventional, Homeopathic Drugs; Finds Strong Similarities A new study comparing the standards by which homeopathic medicines are regulated to conventional drugs and dietary supplements shows that homeopathic medicines undergo extensive Food and Drug Administration (FDA) pre-market evaluation that more resembles traditional pharma than dietary supplements. Study Compares Regulation of Conventional, Homeopathic Drugs; Finds Strong Similarities A new study comparing the standards by which homeopathic medicines are regulated to conventional drugs and dietary supplements shows that homeopathic medicines undergo extensive Food and Drug Administration (FDA) pre-market evaluation that more resembles traditional pharma than dietary supplements. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. Research Supports Effectiveness Of Biocell Collagen II(r) In Promoting Skin Health Bioassay report states the effectiveness of BioCell Collagen II(r) with hyaluronic acid (HA) in inhibiting hyaluronidase. Research Supports Effectiveness Of Biocell Collagen II(r) In Promoting Skin Health Bioassay report states the effectiveness of BioCell Collagen II(r) with hyaluronic acid (HA) in inhibiting hyaluronidase. Research Supports Effectiveness Of Biocell Collagen II(r) In Promoting Skin Health Bioassay report states the effectiveness of BioCell Collagen II(r) with hyaluronic acid (HA) in inhibiting hyaluronidase. Research Supports Effectiveness Of Biocell Collagen II(r) In Promoting Skin Health Bioassay report states the effectiveness of BioCell Collagen II(r) with hyaluronic acid (HA) in inhibiting hyaluronidase. Vitamin D signals to prevent bone loss during osteoporosis In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption. Vitamin D signals to prevent bone loss during osteoporosis In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption. Vitamin D signals to prevent bone loss during osteoporosis In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption. Vitamin D signals to prevent bone loss during osteoporosis In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption. Vitamin D signals to prevent bone loss during osteoporosis In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption. Fish-oil Supplements May Reduce Anger in Substance Abusers Double-blind clinical study of omega-3 essential fatty acid (EFA) supplementation in substance abusers suggests that a patented fish-oil supplement can reduce levels of anger, thereby potentially mitigating aggressive behavior. Fish-oil Supplements May Reduce Anger in Substance Abusers Double-blind clinical study of omega-3 essential fatty acid (EFA) supplementation in substance abusers suggests that a patented fish-oil supplement can reduce levels of anger, thereby potentially mitigating aggressive behavior. Fish-oil Supplements May Reduce Anger in Substance Abusers Double-blind clinical study of omega-3 essential fatty acid (EFA) supplementation in substance abusers suggests that a patented fish-oil supplement can reduce levels of anger, thereby potentially mitigating aggressive behavior. Fish-oil Supplements May Reduce Anger in Substance Abusers Double-blind clinical study of omega-3 essential fatty acid (EFA) supplementation in substance abusers suggests that a patented fish-oil supplement can reduce levels of anger, thereby potentially mitigating aggressive behavior. Study Examines Chocolate Chip Cookie with Soluble Fiber, Plant Sterols, and Impact on Cholesterol double-blind, placebo-controlled cross-over study indicates that specially formulated chocolate chip cookie containing soluble fiber and plant sterols led to a significant decrease in total cholesterol and LDL cholesterol in patients who ate two chocolate chip Right Direction Cookies(tm) each day for 30 days. Study Examines Chocolate Chip Cookie with Soluble Fiber, Plant Sterols, and Impact on Cholesterol double-blind, placebo-controlled cross-over study indicates that specially formulated chocolate chip cookie containing soluble fiber and plant sterols led to a significant decrease in total cholesterol and LDL cholesterol in patients who ate two chocolate chip Right Direction Cookies(tm) each day for 30 days. Kaneka Corporation Of Japan Announces Safety Study Results Of KanekaQ10(TM) On Healthy Subjects Double blind, randomized placebo-controlled trial in Japan, published in papers at the Japan Health Medicine Association, observes that KanekaQ10 in healthy subjects was well tolerated in dosages up to 900mg per day. Kaneka Corporation Of Japan Announces Safety Study Results Of KanekaQ10(TM) On Healthy Subjects Double blind, randomized placebo-controlled trial in Japan, published in papers at the Japan Health Medicine Association, observes that KanekaQ10 in healthy subjects was well tolerated in dosages up to 900mg per day. Study Shows Standardized White Bean Extract Reduces the GI of White Bread Randomized, crossover study, presented at the Third Annual Natural Supplements: An Evidence-Based Update Conference, Sponsored by the Scripps Center for Integrative Medicine, indicates that at a dose of 3000 mg of Phase 2 brand white bean extract, the GI of white bread was reduced by 20.23 points, or 39.07%. Study Shows Standardized White Bean Extract Reduces the GI of White Bread Randomized, crossover study, presented at the Third Annual Natural Supplements: An Evidence-Based Update Conference, Sponsored by the Scripps Center for Integrative Medicine, indicates that at a dose of 3000 mg of Phase 2 brand white bean extract, the GI of white bread was reduced by 20.23 points, or 39.07%. ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake. ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake. ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake. ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	DENVER, Jan 17, 2006 /PRNewswire-FirstCall via COMTEX/ -- Lifeline Therapeutics, Inc. (LFLT) announced data from a human study just published in the scientific journal, Free Radical Biology & Medicine (Jan. 15, 2006), demonstrated Protandim(R) was able to reduce oxidative stress in men and women. Oxidative stress results when the balance between oxidants and antioxidant enzymes is upset. Oxidative stress, which many authorities believe is central to the cellular aging process, increases as we age. Furthermore, there are over a thousand scientific research studies indicating that high oxidative stress is associated with various diseases. Protandim(R), a patent-pending dietary supplement product consisting of five naturally occurring plant ingredients, significantly reduced harmful oxidants by inducing the body to produce more of its own antioxidant enzymes. The study measured the levels of TBARS (thiobarbituric acid-reactive substances), harmful substances created when cells are damaged by oxidation, in 29 subjects. People taking Protandim(R) experienced reduced oxidative stress, as demonstrated by reducing the amount of TBARS circulating in the blood by an average of 40 percent. This reduced oxidative stress occurred as a result of significantly increasing the activity of antioxidant enzymes that naturally help regulate healthy oxidative balance. "These results represent a whole new approach to antioxidant therapy," said senior study author Joe M. McCord, Ph.D., professor of medicine at the University of Colorado Denver Health Sciences Center. "Our review of the literature has found that studies with traditional antioxidant compounds have failed to eliminate the age-related increase in oxidative stress that we have seen in this study, suggesting that Protandim(R) may offer a much more efficient way to reduce oxidative stress." Oxidative stress and its effects in the body Oxidants, which include free radicals, are toxic by-products of human cells as they produce energy to perform their specific metabolic functions. Oxidants are neutralized or detoxified by naturally occurring antioxidant enzymes within cells, including superoxide dismutase and catalase (SOD and CAT). Oxidative stress results when there is a disruption in the balance between oxidants and antioxidant enzymes. One specific measure of oxidative stress is TBARS, harmful products of lipid (fat) oxidation found in the blood. Lower levels of TBARS are seen in healthy and younger individuals. As people age, and in certain diseases, the amount of TBARS circulating in the blood increases, indicating elevated oxidative stress levels. Protandim(R) study results In this study, before starting Protandim(R), study participants, who ranged in age from 20 to 78, showed a strong age-related increase in TBARS. After 30 days of taking Protandim(R), a 40 percent average decrease in TBARS was seen, and the age-related increase was eliminated. By 120 days of supplementation, Protandim(R) also significantly increased activity of SOD and CAT antioxidant enzymes by 30 percent and 54 percent, respectively. "These results show not only that specific harmful substances can be decreased by Protandim(R), but that oxidative stress can be reduced by a natural process, increasing the body's ability to get rid of the harmful substances by increasing the activity of antioxidant enzymes," said Dr. McCord. Much more is being learned about the relationship of oxidative stress with the cellular aging process and with certain diseases. A recent review of multiple studies concluded oxidative stress is strongly associated with the cellular aging process.(1) Furthermore, a recent study concluded that TBARS may be a predictor of cardiovascular events in patients with stable coronary artery disease.(2) "As we learn more about the effects of oxidative stress on cellular aging and certain diseases, we can begin to think about new approaches to maintaining low levels of oxidative stress for long-term health," said Rajindar Sohal, Ph.D., professor of molecular pharmacology and toxicology at the University of Southern California, and a researcher in oxidative stress. Stephen Onody, chief executive officer of Lifeline Therapeutics, makers of Protandim(R), commented on Lifeline Therapeutics' corporate approach to the science of oxidative stress. "We believe today's consumers of dietary supplements are asking for more scientific data to demonstrate the value of the products they choose. It is our goal to continue supporting research not only to help differentiate Protandim(R) as a unique approach to antioxidant therapy, but also further define the science behind oxidative stress." The paper in its entirety will be posted to http://www.protandim.com upon availability. References (1) Junqueira, V. B.; Barros, S. B.; Chan, S. S.; Rodrigues, L.; Giavarotti, L.; Abud, R. L.; Deucher, G. P. Aging and oxidative stress. Mol. Aspects Med. 25:5-16; 2004. (2) Walter, M. F.; Jacob, R. F.; Jeffers, B.; Ghadanfar, M. M.; Preston, G. M.; Buch, J.; Mason, R. P. Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study. J. Am. Coll. Cardiol. 44:1996-2002; 2004. About Joe M. McCord, Ph.D. Dr. McCord currently serves as professor of medicine at the University of Colorado Denver Health Sciences Center and also is director of science for Lifeline Therapeutics. In 1969, Dr. McCord, together with Irwin Fridovich, discovered superoxide dismutase (SOD), spawning an avalanche of research. For this work, he and Fridovich were awarded the Elliot Cresson Medal. In 1997, Dr. McCord received a lifetime achievement award from the Oxygen Society for outstanding contributions to the field of free radical biology and medicine. Dr. McCord is president of the International Society of Antioxidants in Nutrition and Health (ISANH), and he serves on the editorial board of the journal Free Radical Biology & Medicine. Dr. McCord beneficially owns 1.6 million shares of Lifeline Therapeutics common stock. About the Free Radical Biology & Medicine Journal Free Radical Biology & Medicine is the official journal of the Society for Free Radical Biology and Medicine, and is an affiliate journal of the International Society for Free Radical Research. The peer-reviewed journal is one of the highest impact factor journals in the field and is listed by all the major indexing services, including Current Contents, Index Medicus, Science Citation, Chemical Abstracts, and Current Awareness in Biological Sciences and Toxicology Abstracts. The journal encompasses chemical, biochemical, genetic, molecular biology, cell biology, cell signaling, physiological, pharmacological, pathological, toxicological, and medical approaches to oxygen and free radical research. About Lifeline Therapeutics Lifeline Therapeutics, Inc., is a publicly traded company (LFLT) based in Denver, Colo., that markets Protandim(R), a patent-pending dietary supplement that increases the body's natural antioxidant protection. Lifeline Therapeutics is committed to helping people achieve health and wellness ... for life. Oxidative stress (cell damage caused by free radicals) occurs as a person ages or is subjected to stresses such as certain illnesses. TBARS are harmful, reactive substances that indicate the level of oxidative stress in the body. New data from a scientific study in men and women show that after 30 days of taking Protandim(R), the level of circulating TBARS decreased an average of 40 percent, and the age-related increase in TBARS was eliminated. Protandim(R) strengthens a person's defenses against oxidative stress by increasing the body's natural activity of antioxidant enzymes. For more information, please visit the Protandim(R) product Web site at http://www.protandim.com . Except for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and applicable common law. These statements involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Company's control. Other important factors that the Company believes might cause such differences include the Company's limited cash flow and the rapid development of technology, lack of liquidity for the Company's common stock, working capital shortages, the length of time for scientific advances to reach the market (if they ever reach the market), among other risks. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in the Company's filings with the Securities and Exchange Commission.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software